Home
>
National Drug Code (NDC)
>
Prempro
Prempro - 0046-1105-11 - (CONJUGATED ESTROGENS and MEDROXYPROGESTERONE ACETATE)
Drug Information of Prempro
| Product NDC: | 0046-1105 |
| Proprietary Name: | Prempro |
| Non Proprietary Name: | CONJUGATED ESTROGENS and MEDROXYPROGESTERONE ACETATE |
| Active Ingredient(s): | .3; 1.5 mg/1; mg/1 & nbsp; CONJUGATED ESTROGENS and MEDROXYPROGESTERONE ACETATE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, SUGAR COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Prempro
| Product NDC: | 0046-1105 |
| Labeler Name: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020527 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090921 |
Package Information of Prempro
| Package NDC: | 0046-1105-11 |
| Package Description: | 1 BLISTER PACK in 1 CARTON (0046-1105-11) > 28 TABLET, SUGAR COATED in 1 BLISTER PACK |
NDC Information of Prempro
| NDC Code | 0046-1105-11 |
| Proprietary Name | Prempro |
| Package Description | 1 BLISTER PACK in 1 CARTON (0046-1105-11) > 28 TABLET, SUGAR COATED in 1 BLISTER PACK |
| Product NDC | 0046-1105 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CONJUGATED ESTROGENS and MEDROXYPROGESTERONE ACETATE |
| Dosage Form Name | TABLET, SUGAR COATED |
| Route Name | ORAL |
| Start Marketing Date | 20090921 |
| Marketing Category Name | NDA |
| Labeler Name | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
| Substance Name | ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE |
| Strength Number | .3; 1.5 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Estrogen [EPC],Estrogen Receptor Agonists [MoA],Estrogens, Conjugated (USP) [Chemical/Ingredient],Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |
